Article Text

Download PDFPDF
Should nifedipine be used to counter low blood sugar levels in children with persistent hyperinsulinaemic hypoglycaemia?
  1. Dominik Müller1,
  2. Miriam Zimmering2,
  3. Charles Christoph Roehr3
  1. 1Department of Pediatric Nephrology, Charité, Humboldt University, Berlin, Germany
  2. 2Department of Pediatric Nephrology, Charité, Humboldt University, Berlin, Germany
  3. 3Department of Neonatology, Charité Campus Mitte, Humboldt University, Berlin, Germany; christoph.roehr@charite.de

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A 5 year old boy, suffering from hyperinsulinaemic hypoglycaemia since infancy and arterial hypertension secondary to polycystic kidney disease, was given nifedipine (0.3 mg/kg three times a day) to treat his high blood pressure. Normotension was restored and his blood sugar levels normalised. We wondered whether nifedipine could be used safely as long term treatment to counter hypoglycaemia in persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI)?

    Structured clinical question

    In a child with persistent hyperinsulinaemic hypoglycaemia of infancy [patient], can nifedipine [intervention] safely be given to treat hypoglycaemia [outcome]?

    Search strategy and outcome

    Search terms: “persistent hyperinsulinemic hypoglycaemia of infancy” and “hyperinsulinism” and “nifedipine” and “safety” and “calcium antagonist”.

    Cochrane Library (nifedipine or persistent hyperinsulinemic hypoglycaemia of infancy): no relevant study found. PubMed (limits: language English; age 0–18 years): one practice guideline,1 six case reports or patient series of PHHI treated with nifedipine,2–7 one report on …

    View Full Text

    Footnotes

    • Bob Phillips